[an error occurred while processing this directive]
血管通路

尿毒症患者自体动静脉内瘘I型狭窄的临床病理研究

  • 宋文君 ,
  • 梁黎明 ,
  • 陈沁兰 ,
  • 孔祥雷 ,
  • 许冬梅
展开
  • 250014 济南,1山东第一医科大学第一附属医院(山东省千佛山医院)肾病学科
    250014 济南,2山东省肾病研究所

收稿日期: 2023-02-02

  修回日期: 2023-03-17

  网络出版日期: 2023-06-12

基金资助

国家自然科学基金青年基金(82000728);中国初级卫生保健基金会面上项目(HT202112220001);齐鲁卫生与健康杰出青年人才项目(A001358)

Clinicopathological analysis of type I stenosis of autogenous arteriovenous fistula in uremia patients

  • SONG Wen-Jun ,
  • LIANG Li-Ming ,
  • CHEN Qin-Lan ,
  • KONG Xiang-Lei ,
  • XU Dong-Mei
Expand
  • 1Department of Nephrology, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan 250014, China; 2Nephrology Research Institute of Shandong Province, Jinan 250014, China

Received date: 2023-02-02

  Revised date: 2023-03-17

  Online published: 2023-06-12

摘要

目的 探讨尿毒症患者自体动静脉内瘘(autologous arteriovenous fistula,AVF)I型狭窄的临床病理特点。 方法 选取因I型狭窄而行AVF重建手术的患者为研究对象,收集入组患者临床资料。手术中留取废弃狭窄静脉组织与初次行内瘘手术的静脉血管组织做对照,做病理学分析,包括HE染色、Masson染色、免疫组化。 结果 共入组39例患者,平均年龄为(52.7±4.4)岁,62%为男性,糖尿病肾病为首位病因,占43.6%。Pearson相关分析显示:静脉内膜增生(neointimal hyperplasia,NIH)与血磷(r=0.381,P =0.026)呈正相关,与中性粒细胞计数(r=-0.360,P =0.031)呈负相关,与血钙(r=-0.269,P=0.097)和甲状旁腺激素(r=0.007,P=0.971)无相关性。功能不良的内瘘组织HE及Masson染色表现为典型的偏心性NIH。免疫组化提示NIH中内皮细胞标记物CD31、内皮祖细胞标记物CD133、M1巨噬细胞标记物CD68及INOS、M2巨噬细胞标记物CD68及CD206、自然杀伤细胞标记物CD56染色阳性。 结论 对于I型狭窄导致的AVF功能不良,组织病理染色表现为偏心性的NIH,且内膜厚度与血磷和中性粒细胞水平相关。免疫组化提示NIH中除了排列紊乱的内皮细胞,还出现了内皮祖细胞、M1和M2型巨噬细胞及自然杀伤细胞。

本文引用格式

宋文君 , 梁黎明 , 陈沁兰 , 孔祥雷 , 许冬梅 . 尿毒症患者自体动静脉内瘘I型狭窄的临床病理研究[J]. 中国血液净化, 2023 , 22(06) : 453 -457 . DOI: 10.3969/j.issn.1671-4091.2023.06.012

Abstract

Objective  To investigate the clinicopathological characteristics of type I autologous arteriovenous fistula (AVF) stenosis in uremic patients.  Methods  A total of 39 patients who underwent AVF reconstructive surgery for type I stenosis were enrolled in this study. Their clinical data were collected. The stenotic venous tissue cut during the reconstructive surgery and the venous tissue stored during the first AVF constructive surgery were pathologically compared, including HE and masson staining, and immunohistochemistry using antibodies against CD133, CD31, CD68, CD206, iNOS and CD56 to identify the cell types.  Results  The mean age of the 39 patients was 52.7±4.4 years old, 62% were male, and diabetic kidney disease accounted for 43.6% of the patients. HE and Masson staining of the stenotic venous tissues demonstrated typical neointimal hyperplasia (NIH). Pearson correlation analysis showed that NIH was positively correlated with serum phosphorus (r=0.381, P=0.026) and negative correlated with neutrophil count (r=-0.360, P=0.031), but not with serum calcium (r=-0.269, P=0.097) and parathyroid hormone (r=0.007, P=0.971). Immunohistochemical staining showed that positive staining of CD31, CD133, CD206, iNOS, CD68 and CD56 were found in the NIH area in stenotic venous tissues.  Conclusions   Histopathological staining showed an eccentric NIH in the venous tissues from type I AVF stenosis. The thickness of the intimal layer correlated with serum phosphorus level and neutrophil count. Immunohistochemistry showed the presence of abnormally arranged intimal cells, endothelial progenitor cells, M1 and M2 macrophages, and NK cells in NIH areas.

参考文献

[1] VACHHARAJANI T J, TALIERCIO J J, ANVARI E. New Devices and Technologies for Hemodialysis Vascular Access: A Review [J]. American Journal of Kidney Diseases, 2021, 78(1): 116-24.
[2] ALPERS C E, IMREY P B, HUDKINS K L, et al. Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery [J]. J Am Soc Nephrol, 2017, 28(10): 3076-88.
[3] CUI J, XU D, MA J, et al. Stenoses in the surgically manipulated segment have better angioplasty response compared to the surgically naive segment in fistulas [J]. J Vasc Access, 2017, 18(3): 192-9.
[4] ROY-CHAUDHURY P, SUKHATME V P, CHEUNG A K. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint [J]. J Am Soc Nephrol, 2006, 17(4): 1112-27.
[5] DU J, LIANG L, LIU S, et al. Neointimal hyperplasia in the inferior vena cava of adenine-induced chronic kidney disease rats with aortocaval fistulas [J]. Clin Exp Nephrol, 2020, 24(11): 1007-14.
[6] LI Y, CUI W, WANG J, et al. Factors associated with dysfunction of autogenous arteriovenous fistula in patients with maintenance hemodialysis: a retrospective study [J]. Ann Palliat Med, 2021, 10(4): 4047-54.
[7] VILLA-BELLOSTA R. Vascular Calcification: Key Roles of Phosphate and Pyrophosphate [J]. Int J Mol Sci, 2021, 22(24).
[8] BRAHMBHATT A, REMUZZI A, FRANZONI M, et al. The molecular mechanisms of hemodialysis vascular access failure [J]. Kidney Int, 2016, 89(2): 303-16.
[9] SIMONE S, LOVERRE A, CARIELLO M, et al. Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis [J]. J Nephrol, 2014, 27(5): 555-62.
[10] DUAN Y, YU S, XU P, et al. Co-immobilization of CD133 antibodies, vascular endothelial growth factors, and REDV peptide promotes capture, proliferation, and differentiation of endothelial progenitor cells [J]. Acta Biomaterialia, 2019, 96: 137-48.
[11] BUSSOLATI B, COLLINO F, CAMUSSI G. CD133+ cells as a therapeutic target for kidney diseases [J]. Expert Opin Ther Targets, 2012, 16(2): 157-65.
[12] MAUSE S F, RITZEL E, DECK A, et al. Endothelial Progenitor Cells Modulate the Phenotype of Smooth Muscle Cells and Increase Their Neointimal Accumulation Following Vascular Injury [J]. Thromb Haemost, 2022, 122(3): 456-69.
[13] RATTI S, MAURO R, ROCCHI C, et al. Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula [J]. Biomolecules, 2022, 12(3).
[14] MAUSE S F, RITZEL E, DECK A, et al. Engagement of the CXCL12-CXCR4 Axis in the Interaction of Endothelial Progenitor Cell and Smooth Muscle Cell to Promote Phenotype Control and Guard Vascular Homeostasis [J]. Int J Mol Sci, 2022, 23(2).
[15] WYNN T A, CHAWLA A, POLLARD J W. Macrophage biology in development, homeostasis and disease [J]. Nature, 2013, 496(7446): 445-55.
[16] YUNNA C, MENGRU H, LEI W, et al. Macrophage M1/M2 polarization [J]. Eur J Pharmacol, 2020, 877: 173090.
[17] MURRAY P J, ALLEN J E, BISWAS S K, et al. Macrophage activation and polarization: nomenclature and experimental guidelines [J]. Immunity, 2014, 41(1): 14-20.
[18] KRONER A, GREENHALGH A D, ZARRUK J G, et al. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord [J]. Neuron, 2014, 83(5): 1098-116.
[19] LASKIN D L, SUNIL V R, GARDNER C R, et al. Macrophages and tissue injury: agents of defense or destruction? [J]. Annu Rev Pharmacol Toxicol, 2011, 51: 267-88.
[20] VODOVOTZ Y, BOGDAN C, PAIK J, et al. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta [J]. J Exp Med, 1993, 178(2): 605-13.
[21] LIU Y C, ZOU X B, CHAI Y F, et al. Macrophage polarization in inflammatory diseases [J]. Int J Biol Sci, 2014, 10(5): 520-9.
[22] MISRA S, KILARI S, YANG B, et al. Anti Human CX3CR1 VHH Molecule Attenuates Venous Neointimal Hyperplasia of Arteriovenous Fistula in Mouse Model [J]. J Am Soc Nephrol, 2021.
[23] FENYO I M, GAFENCU A V. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis [J]. Immunobiology, 2013, 218(11): 1376-84.
[24] ALEXANDER M R, MOEHLE C W, JOHNSON J L, et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice [J]. J Clin Invest, 2012, 122(1): 70-9.
[25] MENG Q H, IRVINE S, TAGALAKIS A D, et al. Inhibition of neointimal hyperplasia in a rabbit vein graft model following non-viral transfection with human iNOS cDNA [J]. Gene Ther, 2013, 20(10): 979-86.
[26] KUWAHARA G, HASHIMOTO T, TSUNEKI M, et al. CD44 Promotes Inflammation and Extracellular Matrix Production During Arteriovenous Fistula Maturation [J]. Arterioscler Thromb Vasc Biol, 2017, 37(6): 1147-56.
[27] DAMMANAHALLI J K, WANG X, SUN Z. Genetic interleukin-10 deficiency causes vascular remodeling via the upregulation of Nox1 [J]. J Hypertens, 2011, 29(11): 2116-25.
[28] SUWANABOL P A, SEEDIAL S M, SHI X, et al. Transforming growth factor-beta increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways [J]. J Vasc Surg, 2012, 56(2): 446-54.
[29] MATSUBARA Y, KIWAN G, LIU J, et al. Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation [J]. Arterioscler Thromb Vasc Biol, 2021, 41(3): e160-e74.
[30] CHAN J S, WANG Y, CORNEA V, et al. Early Adventitial Activation and Proliferation in a Mouse Model of Arteriovenous Stenosis: Opportunities for Intervention [J]. Int J Mol Sci, 2021, 22(22).
[31] FREUD A G, MUNDY-BOSSE B L, YU J, et al. The Broad Spectrum of Human Natural Killer Cell Diversity [J]. Immunity, 2017, 47(5): 820-33.
[32] HAMIDZADEH K, CHRISTENSEN S M, DALBY E, et al. Macrophages and the Recovery from Acute and Chronic Inflammation [J]. Annu Rev Physiol, 2017, 79: 567-92.
文章导航

/

[an error occurred while processing this directive]